Heart BMJ

DECEMBER 20, 2023

Objectives The effect of subclinical leaflet thrombosis, characterised by hypoattenuated leaflet thickening (HALT), on the valve haemodynamic function and durability of the bioprosthetic valve, is not yet determined.

Aortic valve 40

Aortic valve Thrombosis Aortic TAVR 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionCerebral venous sinus thrombosis (CVST) is a rare form of stroke that usually affects young females especially during pregnancy and the postpartum period. The symptoms of cerebral venous sinus thrombosis can vary depending on the location and extent of the clot.

Thrombosis 40

Thrombosis Cancer Risk Factors Outcomes 40

Cardiovascular Diabetology

FEBRUARY 19, 2024

Early since the onset of the COVID-19 pandemic, the medical and scientific community were aware of extra respiratory actions of SARS-CoV-2 infection. Endothelitis, hypercoagulation, and hypofibrinolysis were i.

COVID-19 111

COVID-19 Thrombosis Diabetes 111

Medical Xpress - Cardiology

FEBRUARY 23, 2024

A gut microbial metabolite called 2-methylbutyrylcarnitine (2MBC) plays a role in exacerbating thrombosis—the formation of blood clots—researchers report February 23 in the journal Cell Metabolism.

Blood Clot 126

Blood Clot COVID-19 Research Thrombosis 126

Frontiers in Cardiovascular Medicine

DECEMBER 17, 2023

Background D-Dimer testing is a diagnostic tool for exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE). This study evaluated the diagnostic performance of the Tina-quant® D-Dimer Gen.2

Thrombosis 64

Thrombosis Embolism Pulmonary Laboratory 64

Stroke Journal

FEBRUARY 1, 2024

Background:Information on long-term care utilization patterns following the acute care period of cerebral venous thrombosis (CVT) is limited. Stroke, Volume 55, Issue Suppl_1 , Page AWMP59-AWMP59, February 1, 2024.

Thrombosis 40

Thrombosis Cancer Stroke Strokes 40

Stroke Journal

FEBRUARY 1, 2024

Background:Cerebral venous thrombosis (CVT) is associated with significant risk of death and disability. Stroke, Volume 55, Issue Suppl_1 , Page AWP260-AWP260, February 1, 2024.

COVID-19 40

COVID-19 Thrombosis Inpatient Hospital 40

ECG Cases

JANUARY 26, 2021

In this month's EM Quick Hits podcast: Justin Morgenstern on which patients to consider cerebral venous thrombosis in, Maria Ivankovic on diphenhydramine alternatives, Brit Long on abdominal compartment syndrome, Sarah Reid on neonatal "constipation" - when to worry, and Anand Swaminathan on intubating the patient with metabolic acidosis.

Thrombosis 52

Thrombosis Pediatrics 52

Stroke Journal

FEBRUARY 1, 2024

Introduction:Seizures are a common initial manifestation of cerebral venous thrombosis (CVT).

Thrombosis 40

Thrombosis Risk Factors Hemorrhage Outcomes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionCerebral sinus venous thrombosis (CSVT) has traditionally been treated medically with systemic anticoagulation. Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Recent advances in endovascular therapy (EVT) may represent an alternative treatment to medical therapy for CSVT.

Thrombosis 40

Thrombosis Outcomes Stroke Strokes 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:Exposure to high altitude environment is a risk factor of cerebral venous thrombosis (CVT) probably due to the hypercoagulability. Stroke, Volume 55, Issue Suppl_1 , Page ATP267-ATP267, February 1, 2024.

Thrombosis 40

Thrombosis Risk Factors Hospital Hemorrhage 40

Know Your Heart

FEBRUARY 20, 2019

Deep Vein Thrombosis What is deep vein thrombosis? Deep vein thrombosis (DVT) occurs when a blood clot forms in a deep-lying vein, usually in the legs. Such a clot is dangerous because the clot may break loose, travel through your bloodstream, and block arteries in your lungs, causing permanent damage or death.

Thrombosis 40

Thrombosis Blood Clot Heart Disease 40

American College of Cardiology

JANUARY 9, 2024

Active cancer is a strong risk factor for venous thromboembolism (VTE) events and recurrent events following discontinuation of anticoagulation therapy, and cancer patients are also at a heightened risk for bleeding complications related to anticoagulation treatment.

Cancer 62

Cancer Thrombosis Risk Factors Article 62

American Heart News - Stroke News

JANUARY 29, 2024

DALLAS, January 29, 2024 — A new scientific statement from the American Heart Association emphasizes the need to increase patients’ and physicians’ awareness of cerebral venous thrombosis (CVT) to improve the recognition of this condition and initiate.

Risk Factors 133

Risk Factors Thrombosis Stroke Strokes 133

Stroke Journal

FEBRUARY 1, 2024

Background:Direct oral anticoagulants (DOACs) are suitable for some patients with cerebral venous thrombosis (CVT). Stroke, Volume 55, Issue Suppl_1 , Page AWP149-AWP149, February 1, 2024. The optimal transition strategy from parenteral anticoagulation (PA) to DOAC is not known.

Thrombosis 40

Thrombosis Outcomes Hemorrhage Stroke 40

European Journal of Heart Failure

OCTOBER 31, 2023

The present document represents the consensus view of the ESC Council on Stroke, the Heart Failure Association and the ESC Working Group on Thrombosis to summarize current insights on pathophysiologic interactions of the heart and the brain in the comorbidity of HF and stroke.

Heart Failure 40

Heart Failure Thrombosis Stroke Strokes 40

Frontiers in Cardiovascular Medicine

MARCH 12, 2024

Intraluminal thrombus formation (ILT) is a recently discovered and highly clinically relevant complication after frozen elephant trunk implantation in cardiovascular surgery.

Stents 59

Stents Stent Risk Factors Thrombosis 59

Frontiers in Cardiovascular Medicine

FEBRUARY 1, 2024

In addition, with the prevalence of COVID-19 infection, more and more studies report that COVID-19 infection may lead to arteriovenous thrombosis, which could cause lower limb ischemia. Clinically, they are mainly seen in the form of popliteal artery entrapment syndrome (PAES).

COVID-19 64

COVID-19 Ischemia Thrombosis 64

Frontiers in Cardiovascular Medicine

FEBRUARY 15, 2024

The scores of the Venous Thrombosis Knowledge, Participation in Thrombosis Prevention Willingness and Behavior Questionnaire, and Quality of Life Measurement Scale (QLQ-C30) were compared before the intervention and after three months.

Cancer 49

Cancer Thrombosis Quality of Life Nursing 49

Cardiology Update

FEBRUARY 11, 2024

Bioprosthetic valve dysfunction (BVD) was categorized into structural valve deterioration (SVD), non-structural valve dysfunction (NSVD), clinical valve thrombosis, or endocarditis. No cases of clinical valve thrombosis were reported. Severe SVD was defined by specific criteria.

Aortic valve 105

Aortic valve Aortic Outcomes Thrombosis 105

Journal of Cardiothoracic Surgery

MARCH 10, 2024

Prosthetic valve thrombosis (PVT) in aortic valve and its complication coronary embolism is a very rare condition. Diagnosis and treatment process is challenging. We present a young patient with acute myocardi.

Aortic valve 52

Aortic valve Embolism Myocardial Infarction Aortic 52

Journal of Cardiovascular Pharmacology

APRIL 9, 2024

Clinical practice shows that a critical unmet need in the field of thrombosis prevention is the availability of anticoagulant therapy without bleeding risk. Clinical practice shows that a critical unmet need in the field of thrombosis prevention is the availability of anticoagulant therapy without bleeding risk.

Thrombosis 40

Thrombosis Article 40

Cardiovascular Diabetology

DECEMBER 7, 2023

Subjects with type 2 diabetes (T2D) have a higher risk of in-stent restenosis and stent thrombosis. The activation of the glucagon-like peptide-1 receptor (GLP-1R) has been suggested to induce several effects.

Diabetes 64

Diabetes Thrombosis Stents Stent 64

Journal of the American Heart Association

JANUARY 12, 2024

Journal of the American Heart Association, Ahead of Print.

Thrombosis 40

Thrombosis Stents Stent 40

DAIC

MAY 15, 2024

Compared with SAVR, self-expanding TAVR prostheses demonstrated lower death or stroke risk (P=0.06), valve thrombosis (P= 0.06), and valve gradients (P For more information: www.scai.org If you enjoy this content, please share it with a colleague

Aortic valve 91

Aortic valve TAVR Outcomes Aortic 91

HeartRhythm

APRIL 30, 2024

Novel oral anticoagulants (NOACs) effectively reduce the prevalence of LAA thrombosis and stroke risk. Left atrial appendage (LAA) thrombus is the primary cause of stroke and systemic embolism in atrial fibrillation (AF).

Atrial Fibrillation 40

Atrial Fibrillation Thrombosis Embolism Stroke 40

The British Journal of Cardiology

MAY 14, 2024

The prospect of uncoupling the management of thrombosis from the bleeding risk inadvertently associated with current therapy inspired the development of agents directed towards this step in the coagulation process.

Pharmacology 52

Pharmacology Thrombosis Physiology Atrial Fibrillation 52

Stroke Journal

OCTOBER 5, 2023

Stroke, Volume 54, Issue 12 , Page e494-e495, December 1, 2023.

Thrombosis 40

Thrombosis Stroke Strokes 40

Heart BMJ

APRIL 15, 2024

Outcomes included heart failure (HF), venous thromboembolism (VTE) and arterial thrombosis/thromboembolism (ATE) recorded in four time windows after SARS-CoV-2 infection: 0–30, 31–90, 91–180 and 181–365 days. Vaccination status was used as a time-varying exposure.

COVID-19 98

COVID-19 Thrombosis Heart Failure Outcomes 98

Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2024

Phlegmasia cerulea dolens (PCD) is a rare yet severe complication of deep vein thrombosis (DVT), characterized by a high amputation rate and mortality. Early diagnosis and treatment are crucial in managing this condition. PCD predominantly affects the lower extremities rather than the upper extremities.

Embolism 64

Embolism Cancer ICU Thrombosis 64

The American Journal of Cardiology

MARCH 7, 2024

Publication date: Available online 7 March 2024 Source: The American Journal of Cardiology Author(s): Federica Troisi, Pietro Guida, Nicola Vitulano, Federico Quadrini, Antonio Di Monaco, Giuseppe Patti, Massimo Grimaldi

Thrombosis 40

Thrombosis Atrial Fibrillation Ablation 40

Stroke Journal

FEBRUARY 1, 2024

In severe OHSS, increases in capillary permeability can result in hemoconcentration and hypercoagulability leading to thrombotic events, including stroke and cerebral venous thrombosis. Within the HCUP cohort, fewer than 10 patients (<1%) were hospitalized with a stroke or thrombotic event within 60 days of OHSS diagnosis.

Thrombosis 40

Thrombosis Inpatient Embolism Myocardial Infarction 40

Heart BMJ

NOVEMBER 27, 2023

(Charles Darwin) Despite being proposed more than three decades ago, dual antiplatelet therapy has become a cornerstone of medical treatment for patients suffering from acute coronary syndrome after the introduction of bare metal stents to overcome the risk of restenosis and stent thrombosis associated with such devices.

Thrombosis 40

Thrombosis Stents Stent 40

Circulation

FEBRUARY 12, 2024

The secondary outcomes included ischemia-driven target lesion revascularization, target vessel myocardial infarction, death, cardiac death, target vessel revascularization, stent thrombosis, and major adverse cardiac events. OCT was associated with a significant reduction of stent thrombosis compared with ICA (OR, 0.49 [95% CI, 0.26–0.92])

Ultrasound 67

Ultrasound Myocardial Infarction Thrombosis Stents 67

Journal of Cardiovascular Pharmacology

FEBRUARY 28, 2024

However, despite a heterogenous substrate underlying coronary thrombosis, treatment remains identical. However, despite a heterogenous substrate underlying coronary thrombosis, treatment remains identical.

Plaque 40

Plaque Thrombosis Atherosclerosis Article 40

Frontiers in Cardiovascular Medicine

JANUARY 30, 2024

There were two self-resolving arterial dissections, one sub-occlusive arterial thrombosis (resolved with 6 weeks of enoxaparin), and one occlusive arterial thrombosis (resolved with alteplase thrombolysis and 6 weeks of enoxaparin). The median fluoroscopy time was 26.1 min min (IQR, 19.2–34.8). Median follow-up was 11.7

Pediatrics 49

Pediatrics Congenital Heart Disease Thrombosis Angioplasty 49

EMS 12-Lead

SEPTEMBER 6, 2022

Coronary thrombosis is a dynamic process of platelet aggregation and subsequent coagulation. During spontaneous reperfusion -- whether via thrombolysis, or recruitment of collateral circulation -- there exists characteristic ST/T changes on the ECG. Case Review: [link]

Thrombosis 52

Thrombosis Thrombolysis Circulation 52